Cigna Group (CI) revenue
Cigna Group (CI) reported revenue of $273.85B in fiscal 2025 (the year ended December 31, 2025). That is 11.3% higher than the $246.15B of fiscal 2024. Figures as of 18 Nov 2026, 06:33 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Revenue, fiscal 2025
- $273.85B
- Change on fiscal 2024
- +11.3%
- Growth, 5 years
- +11.3% a year
- Highest on record
- $273.85Bfiscal 2025
- Lowest on record
- $39.84Bfiscal 2016
- Fiscal years on record
- 102016–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Cigna Group revenue, in more detail
Over the five fiscal years to 2025 revenue grew at a compound 11.3% a year. Across the 10 fiscal years on record (2016–2025), the highest was $273.85B in fiscal 2025 and the lowest $39.84B in fiscal 2016.
Revenue by fiscal year
Cigna Group revenue, year by year
| Fiscal year | Revenue | Change | Year ended |
|---|---|---|---|
| 2025 | $273.85B | 11.3% up | |
| 2024 | $246.15B | 26.8% up | |
| 2023 | $194.10B | 8.2% up | |
| 2022 | $179.36B | 3.0% up | |
| 2021 | $174.07B | 8.5% up | |
| 2020 | $160.40B | 4.5% up | |
| 2019 | $153.57B | 215.7% up | |
| 2018 | $48.65B | 16.4% up | |
| 2017 | $41.81B | 4.9% up | |
| 2016 | $39.84B | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.
How to read it
Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.
Revenue at health care companies of similar size
| Company | Revenue | Fiscal year |
|---|---|---|
| Regeneron Pharmaceuticals REGN | $14.34B | 2025 |
| Elevance Health ELV | $199.13B | 2025 |
| Cigna Group CI | $273.85B | 2025 |
| Takeda Pharmaceutical TAK | ¥4.51T | 2026 |
| Cencora COR | $321.33B | 2025 |
| Boston Scientific BSX | $20.07B | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Cigna Group, figure by figure
- Cigna Group market cap
- Cigna Group earnings
- Cigna Group earnings per share (EPS)
- Cigna Group P/E ratio
- Cigna Group P/S ratio
- Cigna Group P/B ratio
- Cigna Group free cash flow
- Cigna Group operating margin
- Cigna Group dividend
- Cigna Group shares outstanding
- Cigna Group total debt
- Cigna Group cash on hand
- Cigna Group total assets
- Cigna Group return on equity (ROE)
- Cigna Group return on invested capital (ROIC)
Cigna Group (CI) overview: price, valuation and scorecardAll health care companies by market value
Cigna Group revenue: questions and answers
What is Cigna Group's revenue?
Cigna Group (CI) reported revenue of $273.85B in fiscal 2025 (the year ended December 31, 2025). That is 11.3% higher than the $246.15B of fiscal 2024.
What is the growth rate of Cigna Group's revenue?
Over the five fiscal years to 2025 revenue grew at a compound 11.3% a year.
What are the highest and lowest revenue figures on record for Cigna Group?
Across the 10 fiscal years on record (2016–2025), the highest was $273.85B in fiscal 2025 and the lowest $39.84B in fiscal 2016.
How is Cigna Group's revenue calculated?
Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.
Fiscal years are named for the calendar year they end in.
Learn: revenue
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Cigna Group (CI) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/CI/revenue
Underlying data: the company's filings with the SEC and Yahoo Finance.